AP2069A - 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors - Google Patents

2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors

Info

Publication number
AP2069A
AP2069A AP2008004679A AP2008004679A AP2069A AP 2069 A AP2069 A AP 2069A AP 2008004679 A AP2008004679 A AP 2008004679A AP 2008004679 A AP2008004679 A AP 2008004679A AP 2069 A AP2069 A AP 2069A
Authority
AP
ARIPO
Prior art keywords
amino
substituted
protease inhibitors
hiv protease
benzothiazole sulfonamide
Prior art date
Application number
AP2008004679A
Other languages
English (en)
Other versions
AP2008004679A0 (en
Inventor
Kock Herman Augustinus De
Tim Hugo Maria Jonckers
Paul Jozef Gabriel Maria Boonants
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of AP2008004679A0 publication Critical patent/AP2008004679A0/xx
Application granted granted Critical
Publication of AP2069A publication Critical patent/AP2069A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AP2008004679A 2006-06-23 2007-06-22 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors AP2069A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06116003 2006-06-23
PCT/EP2007/056235 WO2007147884A1 (en) 2006-06-23 2007-06-22 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors

Publications (2)

Publication Number Publication Date
AP2008004679A0 AP2008004679A0 (en) 2008-12-31
AP2069A true AP2069A (en) 2009-12-08

Family

ID=37596252

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2008004679A AP2069A (en) 2006-06-23 2007-06-22 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors

Country Status (30)

Country Link
US (1) US8202887B2 (OSRAM)
EP (1) EP2035432B1 (OSRAM)
JP (1) JP5232776B2 (OSRAM)
KR (1) KR101419320B1 (OSRAM)
CN (1) CN101479275B (OSRAM)
AP (1) AP2069A (OSRAM)
AR (1) AR061619A1 (OSRAM)
AT (1) ATE544769T1 (OSRAM)
AU (1) AU2007262943B2 (OSRAM)
BR (1) BRPI0713487B1 (OSRAM)
CA (1) CA2653233C (OSRAM)
CL (1) CL2007001826A1 (OSRAM)
CY (1) CY1112971T1 (OSRAM)
DK (1) DK2035432T3 (OSRAM)
EA (1) EA016387B1 (OSRAM)
ES (1) ES2381129T3 (OSRAM)
IL (1) IL195381A (OSRAM)
JO (1) JO2841B1 (OSRAM)
MX (1) MX2009000160A (OSRAM)
MY (1) MY146805A (OSRAM)
NZ (1) NZ573286A (OSRAM)
PE (1) PE20080342A1 (OSRAM)
PL (1) PL2035432T3 (OSRAM)
PT (1) PT2035432E (OSRAM)
SI (1) SI2035432T1 (OSRAM)
TW (1) TWI415851B (OSRAM)
UA (1) UA96445C2 (OSRAM)
UY (1) UY30416A1 (OSRAM)
WO (1) WO2007147884A1 (OSRAM)
ZA (1) ZA200810350B (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3090B1 (ar) 2009-12-11 2017-03-15 Janssen Sciences Ireland Uc 5- امينو-4- هيدروكسي-بنتويل اميدات
CN103209963A (zh) 2010-07-02 2013-07-17 吉里德科学公司 作为hiv抗病毒化合物的2-喹啉基-乙酸衍生物
AU2011274322B2 (en) 2010-07-02 2015-08-13 Gilead Sciences, Inc. Naphth- 2 -ylacetic acid derivatives to treat AIDS
US9024038B2 (en) * 2010-12-27 2015-05-05 Purdue Research Foundation Compunds and methods for treating HIV
ES2707997T3 (es) * 2011-04-21 2019-04-08 Gilead Sciences Inc Compuestos de benzotiazol y su uso farmacéutico
US9376392B2 (en) 2012-01-04 2016-06-28 Gilead Sciences, Inc. 2-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating AIDS
US9284323B2 (en) 2012-01-04 2016-03-15 Gilead Sciences, Inc. Naphthalene acetic acid derivatives against HIV infection
EP2788336B1 (en) 2012-04-20 2016-03-02 Gilead Sciences, Inc. Benzothiazol-6-yl acetic acid derivatives and their use for treating an hiv infection
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
US12083099B2 (en) 2020-10-28 2024-09-10 Accencio LLC Methods of treating symptoms of coronavirus infection with viral protease inhibitors

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002083657A2 (en) * 2001-02-14 2002-10-24 Tibotec Pharmaceuticals Ltd. Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors
WO2003049746A2 (en) * 2001-12-12 2003-06-19 Tibotec Pharmaceuticals Ltd. Combination of cytochome p450 dependent protease inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003262561B2 (en) * 2002-08-02 2008-10-16 Tibotec Pharmaceuticals Ltd. Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors
PT1670448E (pt) * 2003-09-30 2008-02-11 Tibotec Pharm Ltd Sulfonamidas inibidoras de hcv

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002083657A2 (en) * 2001-02-14 2002-10-24 Tibotec Pharmaceuticals Ltd. Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors
WO2003049746A2 (en) * 2001-12-12 2003-06-19 Tibotec Pharmaceuticals Ltd. Combination of cytochome p450 dependent protease inhibitors

Also Published As

Publication number Publication date
AU2007262943A1 (en) 2007-12-27
NZ573286A (en) 2011-09-30
ATE544769T1 (de) 2012-02-15
BRPI0713487B1 (pt) 2022-07-26
EP2035432B1 (en) 2012-02-08
JO2841B1 (en) 2014-09-15
CA2653233A1 (en) 2007-12-27
CA2653233C (en) 2015-09-29
UA96445C2 (ru) 2011-11-10
US8202887B2 (en) 2012-06-19
CL2007001826A1 (es) 2008-01-18
IL195381A (en) 2013-01-31
CY1112971T1 (el) 2016-04-13
CN101479275A (zh) 2009-07-08
PL2035432T3 (pl) 2012-07-31
KR20090024257A (ko) 2009-03-06
TWI415851B (zh) 2013-11-21
JP5232776B2 (ja) 2013-07-10
EA200970052A1 (ru) 2009-04-28
UY30416A1 (es) 2008-01-31
PT2035432E (pt) 2012-04-24
HK1125633A1 (en) 2009-08-14
CN101479275B (zh) 2012-03-07
WO2007147884A1 (en) 2007-12-27
AR061619A1 (es) 2008-09-10
SI2035432T1 (sl) 2012-06-29
JP2009541272A (ja) 2009-11-26
ES2381129T3 (es) 2012-05-23
AU2007262943B2 (en) 2012-04-12
ZA200810350B (en) 2010-05-26
EA016387B1 (ru) 2012-04-30
BRPI0713487A8 (pt) 2018-01-02
EP2035432A1 (en) 2009-03-18
US20090209583A1 (en) 2009-08-20
AP2008004679A0 (en) 2008-12-31
IL195381A0 (en) 2009-08-03
PE20080342A1 (es) 2008-04-25
DK2035432T3 (da) 2012-05-14
MY146805A (en) 2012-09-28
TW200817416A (en) 2008-04-16
MX2009000160A (es) 2009-01-23
KR101419320B1 (ko) 2014-07-14
BRPI0713487A2 (OSRAM) 2012-11-13

Similar Documents

Publication Publication Date Title
ZA200810350B (en) 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors
LTC2178888I2 (lt) Proteazomos inhibitoriai
BRPI0807547A2 (pt) Inibidores de aspartil protease hetercíclicos
ATE530554T1 (de) Serinprotease-hemmer
IL195592A0 (en) Heterocyclic aspartyl protease inhibitors
ATE461202T1 (de) Hiv-integrasehemmer
IL198014A0 (en) Heterocyclic derived metalloprotease inhibitors
DE602007000759D1 (de) Schleifmaschine
IL183850A0 (en) Hiv protease inhibitors
FI20065775L (fi) Rikotuslaitteen työkalun laakerointi
EP2064177A4 (en) PROTEASE INHIBITORS
DE502007000772D1 (de) Handwerkzeugmaschine
DE502007000499D1 (de) Werkzeugmaschine
EP2134336A4 (en) HIV PROTEASE INHIBITORS DERIVED FROM BENZOFURAN
SE0700989L (sv) Verktygsmaskin
DE112007000386A5 (de) Werkzeugmaschine
EP1855672A4 (en) HIV PROTEASE INHIBITORS
SE0600338L (sv) Verktyg
ZA200706305B (en) HIV protease inhibitors
ZA200908771B (en) Cysteine protease inhibitors
ITUD20060225A1 (it) Cardine per una cerniera
IL175280A0 (en) Retroviral protease inhibitors
TWI340135B (en) Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors
EP2168954A4 (en) CYSTEINE PROTEASES INHIBITORS
TH101958B (th) สารยับยั้งแอสพาร์ติค โปรติเอส